0.057  0.007 (14%)		01-17 12:53
Open: 0.057 High: 0.057 Volume: 300		Pre. Close: 0.05 Low: 0.057 Market Cap: 2(M)

Short term
Mid term
Targets	6-month :	0.08	1-year :	0.09
Resists	First :	0.06	Second :	0.08
Pivot price	0.05
Supports	First :	0.04	Second :	0.03
MAs	MA(5) :	0.06	MA(20) :	0.05
	MA(100) :	0.08	MA(250) :	0.1
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	30.8	D(3) :	39.4
RSI	RSI(14): 48.2
52-week	High :	0.43	Low :	0.02

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AFIB ] has closed below upper band by 43.7%. Bollinger Bands are 55.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 32 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.06 - 0.06	0.06 - 0.06
Low:	0.06 - 0.06	0.06 - 0.06
Close:	0.06 - 0.06	0.06 - 0.06

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

Thu, 05 Dec 2024
Acutus Medical Announces Operational Downsizing - The Manila Times

Wed, 04 Dec 2024
Acutus Medical Slashes 70% of Workforce in Major Restructuring, Pivots to Medtronic-Only Operations - StockTitan

Wed, 30 Oct 2024
Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter - Diagnostic and Interventional Cardiology

Thu, 17 Oct 2024
Acutus Medical finalizes settlement with Biotronik, ends agreements - Investing.com

Wed, 08 Nov 2023
Acutus Medical is laying off more than half of its workers - Mass Device

Thu, 20 Jan 2022
Acutus restructures to focus product development activities - BioWorld Online

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	30 (M)
Shares Float	27 (M)
Held by Insiders	9 (%)
Held by Institutions	0 (%)
Shares Short	554 (K)
Shares Short P.Month	985 (K)

EPS	-0.21
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.16
Profit Margin	0 %
Operating Margin	-62.3 %
Return on Assets (ttm)	-14 %
Return on Equity (ttm)	-30 %
Qtrly Rev. Growth	172.3 %
Gross Profit (p.s.)	0
Sales Per Share	0.4
EBITDA (p.s.)	-0.51
Qtrly Earnings Growth	0 %
Operating Cash Flow	-56 (M)
Levered Free Cash Flow	-5 (M)

PE Ratio	-0.29
PEG Ratio	0
Price to Book value	-0.36
Price to Sales	0.13
Price to Cash Flow	-0.04

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.